Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

The pathogenesis of progressive multifocal leukoencephalopathy.

Berger JR, Khalili K.

Discov Med. 2011 Dec;12(67):495-503. Review.

2.

Progressive multifocal leukoencephalopathy.

Weissert R.

J Neuroimmunol. 2011 Feb;231(1-2):73-7. doi: 10.1016/j.jneuroim.2010.09.021. Review.

PMID:
20937530
3.

The link between VLA-4 and JC virus reactivation.

Monaco MC, Major EO.

Expert Rev Clin Immunol. 2012 Jan;8(1):63-72. doi: 10.1586/eci.11.85. Review.

PMID:
22149341
4.

Pathogenesis of progressive multifocal leukoencephalopathy--revisited.

White MK, Khalili K.

J Infect Dis. 2011 Mar 1;203(5):578-86. doi: 10.1093/infdis/jiq097. Epub 2011 Jan 12. Review.

5.

Progressive multifocal leukoencephalopathy: lessons from AIDS and natalizumab.

Berger JR, Houff S.

Neurol Res. 2006 Apr;28(3):299-305. Review.

PMID:
16687057
6.

[New trends in progressive multifocal leukoencephalopathy].

Gasnault J, Taoufik Y.

Rev Neurol (Paris). 2006 Jan;162(1):43-56. Review. French.

PMID:
16446622
7.

Risk of natalizumab-associated progressive multifocal leukoencephalopathy.

Bloomgren G, Richman S, Hotermans C, Subramanyam M, Goelz S, Natarajan A, Lee S, Plavina T, Scanlon JV, Sandrock A, Bozic C.

N Engl J Med. 2012 May 17;366(20):1870-80. doi: 10.1056/NEJMoa1107829.

8.

Advances in the management of PML: focus on natalizumab.

Fox R.

Cleve Clin J Med. 2011 Nov;78 Suppl 2:S33-7. doi: 10.3949/ccjm.78.s2.08. Review. Erratum in: Cleve Clin J Med. 2012 May;79(5):312.

PMID:
22123933
9.

JC virus DNA in cerebrospinal fluid of human immunodeficiency virus-infected patients: predictive value for progressive multifocal leukoencephalopathy.

McGuire D, Barhite S, Hollander H, Miles M.

Ann Neurol. 1995 Mar;37(3):395-9. Erratum in: Ann Neurol 1995 May;37(5):687.

PMID:
7695239
11.

Progressive multifocal leukoencephalopathy and newer biological agents.

Berger JR.

Drug Saf. 2010 Nov 1;33(11):969-83. doi: 10.2165/11537510-000000000-00000. Review.

PMID:
20925435
12.
13.

[Neuropathology of progressive multifocal leukoencephalopathy].

Murayama S, Saito Y.

Brain Nerve. 2007 Feb;59(2):119-24. Review. Japanese.

PMID:
17380776
14.

The basis for modeling progressive multifocal leukoencephalopathy pathogenesis.

Berger JR.

Curr Opin Neurol. 2011 Jun;24(3):262-7. doi: 10.1097/WCO.0b013e328346d2a3.

PMID:
21499097
15.

Reappraisal of progressive multifocal leukoencephalopathy due to simian virus 40.

Stoner GL, Ryschkewitsch CF.

Acta Neuropathol. 1998 Sep;96(3):271-8.

PMID:
9754960
16.

Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoencephalopathy.

Gasnault J, Kahraman M, de Goër de Herve MG, Durali D, Delfraissy JF, Taoufik Y.

AIDS. 2003 Jul 4;17(10):1443-9.

PMID:
12824781
17.

The human JC polyomavirus (JCPyV): virological background and clinical implications.

Hirsch HH, Kardas P, Kranz D, Leboeuf C.

APMIS. 2013 Aug;121(8):685-727. doi: 10.1111/apm.12128. Epub 2013 Jun 19. Review.

PMID:
23781977
18.

Progressive multifocal leukoencephalopathy in persons infected with human immunodeficiency virus, San Francisco, 1981-1989.

Gillespie SM, Chang Y, Lemp G, Arthur R, Buchbinder S, Steimle A, Baumgartner J, Rando T, Neal D, Rutherford G, et al.

Ann Neurol. 1991 Oct;30(4):597-604.

PMID:
1665053
19.

Review of progressive multifocal leukoencephalopathy and natalizumab.

Aksamit AJ.

Neurologist. 2006 Nov;12(6):293-8. Review.

PMID:
17122725
20.

Molecular biology and immunoregulation of human neurotropic JC virus in CNS.

Sweet TM, Del Valle L, Khalili K.

J Cell Physiol. 2002 Jun;191(3):249-56. Review.

PMID:
12012320

Supplemental Content

Support Center